Posted 15th April 2020 by Joshua Sewell
Antibiotics consumption is increasing worldwide, yet these therapies not only destroy pathogens but also damage our vital intestinal flora.
Posted 8th April 2020 by Joshua Sewell
Hyperphagia is a common underlying cause of overweight and obesity. However, the dieting approaches towards weight loss are usually ineffective due to a persistent increase in appetite. Most of the current products in weight management are based on the principle of sugar/fat blockers and binders which has proven to be rather short-term solution.
Posted 6th April 2020 by Joshua Sewell
In 2017 Lisa and Alanna MacFarlane started The Gut Stuff to bring gut health science and nutritional information together for the millennial generation. We spoke to Lisa about educating consumers and marketing products in gut health.
Posted 30th March 2020 by Joshua Sewell
In the last decade, research has well established (relatively speaking) the impact of gut microbiota on host physiology and behaviour. We know that the gut and the brain communicate bidirectionally. The gut-brain axis includes nerval, endocrine and immunologic pathways. What is less well established is whether alterations in gut microbial composition can affect brain structure and function in neurodevelopmental disorders.
Posted 11th March 2020 by Joshua Sewell
A large fraction of the microorganisms that constitute the human microbiome have remained uncultured. Some of the uncultured microbes have close relatives that have been cultured. However, there are also whole groups of microbes that don’t have relatives in culture.
Posted 6th March 2020 by Joshua Sewell
One of the most powerful tools in science is the use of simple models that can represent a wide range of other similar systems.
Posted 26th February 2020 by Joshua Sewell
The vast majority of human-related microbiology focuses on bacteria – the human bacteriome. Frequently, the term “microbiome” is incorrectly confused with “bacteriome”. Advances in DNA sequencing and culturomics have opened the door on the human “mycobiome”, expanding interest beyond bacteria into fungal effects on multiple facets of human health.
Posted 10th February 2020 by Liv Sewell
Ahead of the Microbiome and Probiotics R&D and Business Collaboration Forum, Dr Monty Lyman takes us on a journey through the last decade of ground-breaking skin microbiome research, and peers ahead into the next.